Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID shot’s success ... Wednesday GSK’s former head of vaccine development, Philip Dormitzer ...

Before that, Dormitzer spent six years at Pfizer, where he “had a leadership role” in the development of COVID vaccine Comirnaty as chief scientific officer for RNA and viral vaccines ...

Investigators have interviewed at least two people in the probe ... 335-0739 or sign up here. Pfizer and BioNTech announced the results of their Covid vaccine on Nov. 9, 2020, six days after ...

had told GSK colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until after that year’s election. The scientist disputes that account of what he told colleagues.

More: Free COVID tests no longer available through this government site: How to get a test President Donald Trump has claimed in the past that Pfizer sat on positive data from the vaccine's ...

The scientist at the center of the claims, Phil Dormitzer, previously led viral vaccine research at Pfizer and later became GSK’s head of vaccines R&D. Dormitzer has denied making any claims ...

Citi analyst Geoff Meacham keeps a Neutral rating on Pfizer (PFE) with a $27 price ... company delayed announcing the success of its COVID-19 vaccine until after the 2020 election.

Farmworkers are vaccianted for the coronavirus disease (COVID-19) in California ...

Investing.com -- Pfizer Inc. (NYSE:PFE) stock fell 1.5% following reports that U.S. prosecutors are investigating a claim related to the timing of the company’s Covid-19 vaccine announcement. The ...